高齢乳がん患者における多成分プレハビリテーション (PREHAB-BC65)
Multidimensional Oncogeriatric Prehabilitation in Older Adults With Breast Cancer: A Randomized Controlled Trial Integrating Frailty and Biomarker Assessment
Older adults with breast cancer frequently present with frailty, decreased functional reserve, and increased risk of postoperative complications. Prehabilitation programs have emerged as a promising strategy to improve physical function and clinical outcomes; however, evidence in geriatric oncology remains limited, particularly regarding the role of biological markers in predicting response to such interventions.
This study aims to evaluate the effectiveness of a multicomponent prehabilitation program in older adults with breast cancer, focusing on functional status, clinical outcomes, and quality of life. In addition, the study seeks to characterize biological markers associated with frailty and treatment response, with the goal of identifying potential predictors of benefit from prehabilitation.
Participants will undergo a structured prehabilitation intervention including physical exercise, nutritional optimization, and comprehensive geriatric assessment. Clinical, functional, and biomarker data will be collected longitudinally.
The results of this study may contribute to improving personalized care strategies in geriatric oncology and to identifying patients who are most likely to benefit from prehabilitation programs.
調査の概要
状態
詳細な説明
This study is a prospective, randomized, controlled, single-blind clinical trial designed to evaluate the effectiveness of a multicomponent prehabilitation program in older adults with breast cancer, incorporating biological characterization to explore predictors of treatment response.
The trial will be conducted at the Navarre University Hospital (Pamplona, Spain). A total of 90 ambulatory patients aged 65 years or older with a confirmed diagnosis of breast cancer will be recruited and randomly assigned in a 1:1:1 ratio to usual care, a home-based multicomponent exercise program based on the Vivifrail methodology, or a supervised hospital-based intervention. All participants will undergo baseline frailty screening followed by a comprehensive geriatric assessment to characterize functional, cognitive, nutritional, and clinical status. Assessments will be repeated at predefined time points throughout the perioperative period and during follow-up.
The intervention is structured into preoperative and postoperative phases and includes individualized multicomponent exercise, nutritional optimization, and targeted management of geriatric syndromes. The hospital-based intervention consists of supervised sessions over six weeks (including a 2-week preoperative phase and a 4-week postoperative phase), while the home-based intervention is adapted to baseline functional status.
Clinical, functional, and biological data will be collected longitudinally to evaluate the impact of the intervention and to identify predictors of clinical outcomes and treatment response.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Marta Lorente Escudero, MD
- 電話番号:+34 648148503
- メール:marta.lorente.escudero@navarra.es
研究連絡先のバックアップ
- 名前:Nicolás Martínez Velilla, PhD
- 電話番号:+34 670900434
- メール:nicolas.martinez.velilla@navarra.es
研究場所
-
-
Navarre
-
Pamplona、Navarre、スペイン、31008
- 募集
- Hospital Universitario de Navarra
-
コンタクト:
- Marta Lorente Escudero, MD
- 電話番号:+34 648148503
- メール:marta.lorente.escudero@navarra.es
-
コンタクト:
- Nicolás Martínez Velilla, MD, PhD
- 電話番号:+34 670900434
- メール:nicolas.martinez.velilla@navarra.es
-
主任研究者:
- Nicolás Martínez Velilla, MD, PhD
-
副調査官:
- Bernardo Abel Cedeño Veloz, MD, PhD
-
副調査官:
- Susana de la Cruz Sánchez, MD
-
副調査官:
- Sara Esteban Gordillo, MD
-
副調査官:
- Natalia Moras Pérez, MD
-
副調査官:
- Fabricio Zambom Ferraresi, PhD
-
副調査官:
- Marta Lorente Escudero, MD
-
副調査官:
- Lucía Lozano Vicario, MD, PhD
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Age ≥65 years
- Diagnosis of breast cancer requiring elective surgery with curative intent
- Candidate for prehabilitation program before surgery
- Ability to walk (with or without assistive devices)
- Ability to provide informed consent
Exclusion Criteria:
- Urgent or emergency surgery
- Severe cognitive impairment precluding participation in the intervention
- Severe functional dependency (e.g., bedridden patients)
- Medical contraindication to physical exercise
- Life expectancy <3 months
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし:Usual Care
Participants receive standard clinical care according to routine practice, including management by oncology and surgical teams. Identified geriatric conditions are communicated to the treating physician for appropriate management. |
|
|
実験的:Home-based Multicomponent Prehabilitation (Vivifrail)
Participants perform a home-based multicomponent exercise program based on the Vivifrail methodology, including strength, endurance, balance, and flexibility training over six weeks, comprising a 2-week preoperative phase and a 4-week postoperative phase. The program is tailored according to baseline functional status and supported by caregiver supervision. Participants also receive comprehensive geriatric assessment and nutritional optimization. |
Participants perform a structured home-based multicomponent exercise program based on the Vivifrail methodology, including strength, endurance, balance, and flexibility training over six weeks. The program is individualized according to baseline functional status. Participants undergo comprehensive geriatric assessment with targeted interventions including nutritional optimization, medication review, and management of geriatric syndromes. |
|
実験的:Supervised Multicomponent Prehabilitation
Participants receive a supervised multicomponent exercise program delivered in the hospital setting, including aerobic, resistance, balance, and flexibility training over six weeks, including a 2-week preoperative phase and a 4-week postoperative phase. The intervention is combined with comprehensive geriatric assessment, nutritional optimization, and individualized management of geriatric syndromes. |
Participants undergo comprehensive geriatric assessment with targeted interventions including nutritional optimization, medication review, and management of geriatric syndromes. Participants receive a structured, supervised multicomponent exercise program delivered in a hospital setting, including aerobic, strength, balance, and flexibility training over six weeks. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in physical function assessed by Short Physical Performance Battery (SPPB)
時間枠:Baseline to the end of the 6-week intervention period
|
Physical function will be assessed using the Short Physical Performance Battery (SPPB), a validated tool in older adults (score range 0-12, higher scores indicate better performance). The primary outcome will be the change in SPPB score from baseline to the end of the 6-week intervention period. |
Baseline to the end of the 6-week intervention period
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Incidence of postoperative complications
時間枠:Within 30 days after surgery
|
Occurrence of postoperative complications within 30 days after surgery, classified according to the Clavien-Dindo classification. |
Within 30 days after surgery
|
|
Length of hospital stay
時間枠:From date of surgery until hospital discharge, with a maximum follow-up of 30 days postoperatively
|
Number of days from surgery to hospital discharge. |
From date of surgery until hospital discharge, with a maximum follow-up of 30 days postoperatively
|
|
Functional decline after surgery
時間枠:Baseline to 30 days after surgery
|
Functional decline defined as a decrease in the Short Physical Performance Battery (SPPB) score (range 0 to 12, with higher scores indicating better physical performance) or loss of independence in activities of daily living compared to baseline. |
Baseline to 30 days after surgery
|
|
Health-related quality of life
時間枠:Baseline to 30 days after surgery
|
Health-related quality of life assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30; scores transformed to a 0-100 scale, where higher scores indicate better functioning or worse symptoms depending on the domain). |
Baseline to 30 days after surgery
|
|
Adherence to the intervention
時間枠:During the 6-week intervention period
|
Percentage of prescribed exercise sessions completed by participants. |
During the 6-week intervention period
|
協力者と研究者
スポンサー
捜査官
- スタディディレクター:Marta Lorente Escudero, MD、Navarre Health Service (SNS-O), Navarre University Hospital (HUN), Pamplona, Spain
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- HUN-PREHAB-BC-65
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Individual participant data will not be shared due to data protection regulations and institutional policies. De-identified data may be available from the corresponding author upon reasonable request, subject to ethical approval and data sharing agreements.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。